Recombinant Human ABAT Protein，His & SUMO

ABAT, or amino acid decarboxylase, is an important enzyme involved in the metabolism of amino acids, particularly in the synthesis of γ-aminobutyric acid (GABA), a key inhibitory neurotransmitter in the central nervous system. Research into ABAT has gained momentum due to its potential roles in various physiological and pathological processes, including its implications in neurological disorders such as epilepsy, anxiety, and schizophrenia. The enzyme's activity can influence GABA levels, which are crucial for maintaining neuronal excitability and a balanced mood. Furthermore, alterations in ABAT expression or function have been linked to metabolic disorders and certain neurodevelopmental conditions. The recombinant expression of ABAT allows for the production of the enzyme in a controlled environment, facilitating detailed biochemical studies and the exploration of its structure-function relationships. This has paved the way for the development of novel therapeutic strategies aimed at modulating ABAT activity. By understanding how ABAT operates and its interactions within metabolic pathways, researchers hope to uncover targeted interventions that could restore normal neurotransmitter balance and improve treatment outcomes for patients suffering from related disorders. Given the critical role of GABAergic signaling in the brain, ABAT remains a significant focus in neurobiological research, highlighting the importance of comprehensive studies on its recombinant protein for both basic science and clinical applications.